{
    "title": "Eisai, Biogen's Alzheimer's drug price should not dent demand - analysts",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11614895/Eisai-Biogens-Alzheimers-drug-price-not-dent-demand--analysts.html",
    "date": "2023-01-09",
    "keywords": [
        "price",
        "drug",
        "approval",
        "tag",
        "analyst",
        "biogen",
        "demand",
        "leqembi",
        "pricing",
        "research",
        "note",
        "eisai",
        "medicare",
        "jan",
        "co",
        "ltd",
        "promising",
        "therapy",
        "wall",
        "street",
        "health",
        "regulator",
        "friday",
        "decision",
        "result",
        "bmo",
        "evan",
        "seigerman",
        "aduhelm",
        "controversy",
        "level",
        "scrutiny",
        "skorney",
        "product",
        "case",
        "scenario",
        "decline",
        "access",
        "reimbursement",
        "government",
        "insurance",
        "program",
        "saturday",
        "drugmaker",
        "food",
        "administration",
        "coverage",
        "reporting",
        "mahobe",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}